| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2011 | EP2318008A1 Binding and inhibiting 5-ht4 receptor |
| 05/11/2011 | EP2318007A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/11/2011 | EP2318006A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/11/2011 | EP2318005A1 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
| 05/11/2011 | EP2318004A2 Pharmaceutical compositions containing a crystalline form of posaconazole |
| 05/11/2011 | EP2318003A1 Compositions for the treatment of fibrotic diseases or conditions |
| 05/11/2011 | EP2318002A2 Use of mtor inhibitors to enhance t cell immune responses |
| 05/11/2011 | EP2318001A1 Modified release formulation and methods of use |
| 05/11/2011 | EP2318000A1 Anti-tumoural effects of cannabinoid combinations |
| 05/11/2011 | EP2317999A2 Methods for modulating angiogenesis via dystrophin dp71 |
| 05/11/2011 | EP2317998A1 Fulvic acid and antibiotic combination |
| 05/11/2011 | EP2317997A1 Low dose topiramate/phentermine compostion and methods of use thereof |
| 05/11/2011 | EP2317996A1 Eltoprazine for suppression of l-dopa induced dyskinesias |
| 05/11/2011 | EP2317995A1 Inhbitors of mrp4 and agents stimulating mrp4 activity for the treatment of cardiac disorders |
| 05/11/2011 | EP2317994A2 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 05/11/2011 | EP2317993A2 Methods of administering topical antifungal formulations for the treatment of fungal infections |
| 05/11/2011 | EP2317992A2 Preventing or treating viral infection using an inhibitor of the lsd1 protein, a mao inhibitor or an inhibitor of lsd1 and a mao inhibitor |
| 05/11/2011 | EP2317991A1 Use of opioid antagonists for treating urinary retention |
| 05/11/2011 | EP2317989A2 Microparticles |
| 05/11/2011 | EP2317988A1 Pharmaceutical dosage forms for time-specific drug delivery |
| 05/11/2011 | EP2317987A1 Eprosartan compositions |
| 05/11/2011 | EP2317986A2 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract |
| 05/11/2011 | EP2317985A2 Modified release ramipril compositions and uses thereof |
| 05/11/2011 | EP2317980A2 Pharmaceutical compositions of rivaroxaban with modified release properties |
| 05/11/2011 | EP2317978A2 Stable injectable oil-in-water docetaxel nanoemulsion |
| 05/11/2011 | EP2317976A1 Methods and ophtalmic devices used in the treatment of ocular allergies |
| 05/11/2011 | EP2317864A1 Highly active antioxidant based on trehalulose |
| 05/11/2011 | EP2317857A1 Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth |
| 05/11/2011 | EP2317852A1 Pharmaceutical formulations containing dopamine receptor ligands |
| 05/11/2011 | EP2317849A1 Method for treating pulmonary diseases using rho kinase inhibitor compounds |
| 05/11/2011 | EP2317847A1 Selective inhibition of polyglutamine protein expression |
| 05/11/2011 | EP2317845A1 Methods of treating an overweight or obese subject |
| 05/11/2011 | EP2220053B1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 05/11/2011 | EP2170090B1 Hydroxytyrosol fortified oils and their uses |
| 05/11/2011 | EP2139877B1 Deuterated piperazine derivatives as anti-anginal compounds |
| 05/11/2011 | EP2134708B1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 05/11/2011 | EP2094703B1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 05/11/2011 | EP2072584B1 Phthalocyanine dyes, their preparation and use |
| 05/11/2011 | EP2050444B1 Fatigue-reducing agent |
| 05/11/2011 | EP2042171B1 Therapeutic or prophylactic agent for allergic dermatitis |
| 05/11/2011 | EP2038415B1 Dph2 gene deletion mutant and uses thereof |
| 05/11/2011 | EP1984362B1 Process for preparing intermediates to 5-ht4 receptor agonist compounds |
| 05/11/2011 | EP1968383B1 Derivatives of vitamin d and therapeutic use thereof |
| 05/11/2011 | EP1957061B1 Combination comprising at least one amino acid and a pkr inhibitor for use in the treatment of muscle loss |
| 05/11/2011 | EP1910375B1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 05/11/2011 | EP1900368B1 Tablet containing hardly soluble active ingredient |
| 05/11/2011 | EP1844131B1 Process for the preparation of fatty acids |
| 05/11/2011 | EP1803811B1 Chimeric (double) decoy |
| 05/11/2011 | EP1791823B1 Antibiotic and method for production thereof |
| 05/11/2011 | EP1789036B1 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase |
| 05/11/2011 | EP1763517B1 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 05/11/2011 | EP1711486B1 Bis-indole pyrroles useful as antimicrobial agents |
| 05/11/2011 | EP1606297B1 Preparation of high viscosity xanthan polymers |
| 05/11/2011 | EP1606286B1 Benodiazepine spirohydantoin cgrp receptor antagonists |
| 05/11/2011 | EP1604665B1 C-kit kinase inhibitor |
| 05/11/2011 | EP1594870B1 Substituted indolepyridinium as anti-infective compounds |
| 05/11/2011 | EP1531826B1 Antidepressants for the prophylaxis and treatment of cystic fibrosis |
| 05/11/2011 | EP1458360B1 Pulmonary delivery of aminoglycosides |
| 05/11/2011 | EP1453916B1 Combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 05/11/2011 | EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/11/2011 | EP1372786B1 Cytoprotection by phosphotyrosine |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | EP1163262B1 Phenylalanine derivatives |
| 05/11/2011 | EP1061803B1 Compositions of eprosartan |
| 05/11/2011 | EP1001755B1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/11/2011 | EP0885002B1 Materials and methods for enhancing cellular internalization |
| 05/11/2011 | CN201825901U Production device for heparin sodium medicine |
| 05/11/2011 | CN1997376B Skin conditioning agent |
| 05/11/2011 | CN1993114B Diarylalkanes as potent inhibitors of binuclear enzymes |
| 05/11/2011 | CN1989968B Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 05/11/2011 | CN1943664B The Chinese traditional medicinal cream for treatment of eczema |
| 05/11/2011 | CN1938036B Hemostatic agent for topical and internal use |
| 05/11/2011 | CN1935817B New acyclic nucleoside phosphate ester and its pharmaceutical use |
| 05/11/2011 | CN1931869B Derivative of 5-deoxy-5-fluoro cytidine and its preparation process and use |
| 05/11/2011 | CN1917883B Use of treprostinil in preparing medicine to improve kidney functions |
| 05/11/2011 | CN1909912B Use of ribose in recovery from anaesthesia |
| 05/11/2011 | CN1899614B Preparation for the prophylaxis of restenosis |
| 05/11/2011 | CN1895237B Officinal magnolia phenol lipid frozen dried powder preparation and its use in preparing drug for cancers |
| 05/11/2011 | CN1854148B Astragalus total heteroside extract and its production |
| 05/11/2011 | CN1852740B Multi-arm polymer prodrugs |
| 05/11/2011 | CN1845917B 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament |
| 05/11/2011 | CN1842327B Therapeutic/preventive agent for osteoporosis containing as component isotaxiresinol derived from taxus yunnanensis |
| 05/11/2011 | CN1827627B Novel acyclic nucleoside phosphonic acid and its ester derivatives and pharmaceutical use thereof |
| 05/11/2011 | CN1813812B Liquid capsule for treating diseases caused by pathogenic wind hot and its preparing method |
| 05/11/2011 | CN1809284B Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides |
| 05/11/2011 | CN1798568B Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
| 05/11/2011 | CN1786003B Sulfur, nitrogen heterocyclic naphacyl imine cell compounds and its application in tumour cell |
| 05/11/2011 | CN1665801B Anti tubercular drug: compositions and methods |
| 05/11/2011 | CN1599623B Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 05/11/2011 | CN1596106B Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and complications and/or sequelas |
| 05/11/2011 | CN102057050A Method for producing sphingolipids by enzymatic N-acylation of lysosphingolipids using a lipase and a fatty acid glycerol ester |
| 05/11/2011 | CN102057049A Method for producing sphingolipids by enzymatic N-acylation of lysosphingolipids using a fungal lipase and a fatty acid alkyl ester |
| 05/11/2011 | CN102056933A Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase |
| 05/11/2011 | CN102056932A Thiazolo [5, 4-B] pyridine and oxazolo [5, 4-B] pyridine derivatives as antibacterial agents |
| 05/11/2011 | CN102056930A Halichondrin B analogs |
| 05/11/2011 | CN102056928A Method for producing bicyclic guanidines by use of a cyclic urea |
| 05/11/2011 | CN102056927A Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 05/11/2011 | CN102056926A Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 05/11/2011 | CN102056925A Compounds and compositions as kinase inhibitors |
| 05/11/2011 | CN102056924A Fused ring compounds and use thereof |